BMJ Round Table Shared Decision - Making Practicalities

BMJ Round Table Shared Decision - Making Practicalities

Author: The BMJ August 28, 2013 Duration: 23:31

At BMA house, we convened a group of world experts in shared decision making. Inspired by the Salzburg Global Summit meeting we discussed the background, practical challenges, and how to engage patients with their health

The participants were:

Fiona Godlee , editor in chief, BMJ

Angela Coulter , director of global initiatives, Foundation for Informed Medical Decision Making

Albert Mulley , co-founder, Foundation for Informed Medical Decision Making, and director, Dartmouth Center for Health Care Delivery Science

Glyn Elwyn, research professor with an interest in shared decision making, Cardiff University

Muir Gray , chair of the Information Standard, Department of Health, and co-editor (with Gerd Gigerenzer of the new book Better Doctors, Better Patients, Better Decisions: Envisioning Health Care 2020

Marion Collict, national programme manager, shared decision making, NHS (UK’s National Health System)

Alf Collins , consultant in pain medicine, Taunton and Somerset NHS Foundation Trust, and national clinical lead for Co-Creating Health

Margaret McCartney , writer and GP

Anu Dhir , junior surgical trainee and co-signatory of the Salzburg Statement

Gerd Gigerenzer , director, Center for Adaptive Behaviour and Cognition, Max Planck Institute for Human Behaviour

Lisa Schwartz , professor of medicine, Dartmouth Medical School, author (with Steve Woloshin (see below)) of Know Your Chances available free online.

Steve Woloshin , professor of medicine, Dartmouth Medical School

“e-Patient Dave” deBronkart , co-chair, Society for Participatory Medicine

Tessa Richards , analysis editor, BMJ

Sue Ziebland , research director of the Health Experiences Research Group and a reader in qualitative health research, Department of Primary Health Care, University of Oxford


Produced by The BMJ, this weekly audio series delves into the pivotal research and urgent clinical debates shaping modern medicine. Each episode moves beyond the published page, bringing together the authors, critics, and practitioners directly involved to dissect a new study or a pressing health question. The conversation is rigorous and nuanced, designed for those who appreciate the complexity behind headlines. You’ll hear unscripted discussion about methodology, implications for practice, and the occasional healthy disagreement that drives science forward. This isn't just a summary of the latest findings; it's a critical appraisal in real time, offering listeners a front-row seat to the evolving discourse that defines evidence-based care. The Medicine and Science from The BMJ podcast serves as an essential audio companion for clinicians, academics, and anyone keen to understand the ‘why’ and ‘how’ behind medical news. It transforms the latest evidence from the journal into an accessible, thought-provoking dialogue, ensuring that busy professionals can stay deeply informed. Tune in for a direct, intelligent, and often surprising take on the science that matters most.
Author: Language: English Episodes: 1000

Medicine and Science from The BMJ
Podcast Episodes
Talk Evidence - Radiation, fertility, and pneumonia [not-audio_url] [/not-audio_url]

Duration: 32:13
Helen Macdonald and Carl Heneghan are back again talking about what's happened in the world of evidence this month. They start by talking about how difficult a task it is to find evidence that's definitely practice chang…
Sorry for the interruption in service [not-audio_url] [/not-audio_url]

Duration: 1:18
The problem we had publishing our feed has been fixed, and normal service has resumed. Thank you for subscribing to the podcast, if you have thoughts you'd like to express, we'd love to hear them. https://www.bmj.com/pod…
Safeguarding LGBT+ young people [not-audio_url] [/not-audio_url]

Duration: 28:34
Recent years have seen political and social progress for people who identify as LGBT+ (lesbian, gay, bisexual, and transgender; the “+” indicating inclusion of other minority sexual and gender identities). Yet internatio…
Should we be screening for AF? [not-audio_url] [/not-audio_url]

Duration: 21:05
Current evidence is sufficient to justify a national screening programme, argues Mark Lown clinical lecturer at the University of Southampton, but Patrick Moran, senior research fellow in health economics at Trinity Coll…
Chronic Rhinosinusitis [not-audio_url] [/not-audio_url]

Duration: 36:29
Patients who experience chronic rhinosinusitis may way for a considerable period of time before presenting, because they believe the condition to be trivial. In this podcast, Alam Hannan, ENT Consultant at the Royal Thro…
Assisted dying: should doctors help patients to die? [not-audio_url] [/not-audio_url]

Duration: 29:21
The Royal College of Physicians will survey all its members in February on this most controversial question. It says that it will move from opposition to neutrality on assisted dying unless 60% vote otherwise. The BMJ ex…
Talk evidence - TIAs, aging in Japan and women in medicine [not-audio_url] [/not-audio_url]

Duration: 36:23
In this EBM round-up, Carl Heneghan, Helen Macdonald and Duncan Jarvies are back to give you an update Dual vs single therapy for prevention of TIA or minor stroke - how does the advice that dual work better translate in…
HIV - everything you wanted to know about PeP and PreP [not-audio_url] [/not-audio_url]

Duration: 1:06:32
We have had two articles published recently on bmj.com, looking at drug prevention of HIV; PeP - Post-exposure Prophylaxis and PreP - Pre-exposure Prophylaxis, neither prevent the virus from entering the body, but they d…
HbA1c - when it might not be accurately measuring glycemic control [not-audio_url] [/not-audio_url]

Duration: 17:53
HbA1c concentration is used as the biomarker for long term glycaemic control, however if the lifespan of red blood cells is altered, that may lead to an over, or under estimation of that control. In this podcast Ravinder…